 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 850312
Online Users : 912
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/15923
|
| Title: | Identification of gut microbiome signatures associated with indole pathway in tryptophan metabolism in patients undergoing hemodialysis |
| Authors: | Huang, JK;Wu, PH;Chen, ZF;Liu, PY;Kuo, CC;Chuang, YS;Lu, MZ;Kuo, MC;Chiu, YW;Lin, YT |
| Contributors: | Institute of Cellular and Systems Medicine |
| Abstract: | Microbiota tryptophan metabolism and the biosynthesis of indole derivatives play an important role in homeostasis and pathogenesis in the human body and can be affected by the gut microbiota. However, studies on the interplay between gut microbiota and tryptophan metabolites in patients undergoing dialysis are lacking. This study aimed to identify the gut microbiota, the indole pathway in tryptophan metabolism, and significant functional differences in ESRD patients with regular hemodialysis. We performed the shotgun metagenome sequencing of stool samples from 85 hemodialysis patients. Using the linear discriminant analysis effect size (LEfSe), we examined the composition of the gut microbiota and metabolic features across varying concentrations of tryptophan and indole metabolites. Higher tryptophan levels promoted tyrosine degradation I and pectin degradation I metabolic modules; lower tryptophan levels were associated with glutamate degradation I, fructose degradation, and valine degradation modules. Higher 3-indoxyl sulfate concentrations were characterized by alanine degradation I, anaerobic fatty acid beta-oxidation, sulfate reduction, and acetyl-CoA to crotonyl-CoA. Contrarily, lower 3-indoxyl sulfate levels were related to propionate production III, arabinoxylan degradation, the Entner-Doudoroff pathway, and glutamate degradation II. The present study provides a better understanding of the interaction between tryptophan, indole metabolites, and the gut microbiota as well as their gut metabolic modules in ESRD patients with regular hemodialysis. |
| Date: | 2024-05-24 |
| Relation: | Biomolecules. 2024 May 24;14(6):Article number 623. |
| Link to: | http://dx.doi.org/10.3390/biom14060623 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2218-273X&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:001254595500001 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85197161539 |
| Appears in Collections: | [郭呈欽] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| ISI001254595500001.pdf | | 1511Kb | Adobe PDF | 57 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
